These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1447501)

  • 1. Sodium fluoride prevents bone loss in primary biliary cirrhosis.
    Guañabens N; Parés A; del Rio L; Roca M; Gómez R; Muñoz J; Rodés J
    J Hepatol; 1992 Jul; 15(3):345-9. PubMed ID: 1447501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
    Guañabens N; Parés A; Monegal A; Peris P; Pons F; Alvarez L; de Osaba MJ; Roca M; Torra M; Rodés J
    Gastroenterology; 1997 Jul; 113(1):219-24. PubMed ID: 9207281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C; Devogelaer JP; Depresseux G; Malghem J; Maldague B
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease.
    von Tirpitz C; Klaus J; Brückel J; Rieber A; Scholer A; Adler G; Böhm BO; Reinshagen M
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):19-24. PubMed ID: 10656205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
    Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of osteoporosis in primary biliary cirrhosis.
    Wolfhagen FH; van Buuren HR; Vleggaar FP; Schalm SW
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):629-41. PubMed ID: 10976019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis.
    Ormarsdóttir S; Mallmin H; Naessén T; Petrén-Mallmin M; Broomé U; Hultcrantz R; Lööf L
    J Intern Med; 2004 Jul; 256(1):63-9. PubMed ID: 15189367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
    von Tirpitz C; Klaus J; Steinkamp M; Hofbauer LC; Kratzer W; Mason R; Boehm BO; Adler G; Reinshagen M
    Aliment Pharmacol Ther; 2003 Mar; 17(6):807-16. PubMed ID: 12641503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol for bone loss in patients with primary biliary cirrhosis.
    Shiomi S; Masaki K; Habu D; Takeda T; Nishiguchi S; Kuroki T; Ochi H
    J Gastroenterol; 1999 Apr; 34(2):241-5. PubMed ID: 10213125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis.
    Olsson R; Mattsson LA; Obrant K; Mellström D
    Liver; 1999 Jun; 19(3):188-92. PubMed ID: 10395037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis and osteoporosis: a case-control study.
    Mounach A; Ouzzif Z; Wariaghli G; Achemlal L; Benbaghdadi I; Aouragh A; Bezza A; El Maghraoui A
    J Bone Miner Metab; 2008; 26(4):379-84. PubMed ID: 18600405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.
    Floreani A; Zappala F; Fries W; Naccarato R; Plebani M; D'Angelo A; Chiaramonte M
    J Clin Gastroenterol; 1997 Jun; 24(4):239-44. PubMed ID: 9252849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.